van den Broek Richard
SEC insider (Form 3/4/5 filer). CIK 0001431872. Director at PULSE BIOSCIENCES, INC. (PLSE) and 1 other issuer. 5 reported Form 4/5 transactions since Sep 2024; latest on Jun 11, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies van den Broek Richard has filed insider reports for
- PULSE BIOSCIENCES, INC. (PLSE): Director
- Corvus Pharmaceuticals, Inc. (CRVS): Director
van den Broek Richard
CIK: 0001431872
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jun 11, 2026PLSE
PULSE BIOSCIENCES, INC.
AwardDirectStock Option (right to buy)
30K shares- - Jun 11, 2026PLSE
PULSE BIOSCIENCES, INC.
AwardDirectStock Option (right to buy)
8.4K shares- - Jun 11, 2026CRVS
Corvus Pharmaceuticals, Inc.
AwardDirectStock Option (Right to Buy)
15K shares- - Aug 15, 2025PLSE
PULSE BIOSCIENCES, INC.
AwardDirectStock Option (right to buy)
30K shares- - Apr 8, 2025CRVS
Corvus Pharmaceuticals, Inc.
AwardDirectStock Option (Right to Buy)
30K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 11, 2026 |  PLSE PULSE BIOSCIENCES, INC. | Award Stock Option (right to buy) | 30,000 | - | - | Direct |
| Jun 11, 2026 | PLSE PULSE BIOSCIENCES, INC. | Award Stock Option (right to buy) | 8,423 | - | - | Direct |
| Jun 11, 2026 |  CRVS Corvus Pharmaceuticals, Inc. | Award Stock Option (Right to Buy) | 15,000 | - | - | Direct |
| Aug 15, 2025 | PLSE PULSE BIOSCIENCES, INC. | Award Stock Option (right to buy) | 30,000 | - | - | Direct |
| Apr 8, 2025 | CRVS Corvus Pharmaceuticals, Inc. | Award Stock Option (Right to Buy) | 30,000 | - | - | Direct |
1-5 of 5 transactions